Data thru May 13, 2026
HomeTrendsArticlesDrug MarketsTherapeutic ClassesManufacturersPricingContact
Back to Market Feed

RENVELA 2.4 GM POWDER PACKET

SEVELAMER CARBONATE
$17.1932per EA
High Outlier

Strength

2400 mg/1

Manufacturer

Genzyme Corporation

NDC

58468013102

Classification

Brand

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Last Updated

5/21/2025

Active Ingredients

SEVELAMER CARBONATE

Approval Type

New Drug (NDA)

FDA Application

NDA022318

On Market Since

8/12/2009

Pharmacological Classes

Phosphate Binder
Phosphate Chelating Activity

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

-0.0%

3Y

+5.6%

5Y

+5.6%

All

+84.4%

Generic Alternatives

Save up to 94%

1 alternative • Same active ingredient

SEVELAMER 2.4 GM POWDER PACKET
Generic
65862093190•Aurobindo Pharma Limited
$1.0994
Save 94%

Related Drugs

Same classification

TUMS TABLET CHEWABLE
Brand
00135007003•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007027•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007048•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007127•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135007148•Haleon US Holdings LLC
$0.0274
per EA
TUMS TABLET CHEWABLE
Brand
00135061101•Haleon US Holdings LLC
$0.0274
per EA
TUMS ULTRA TABLET CHEWABLE
Brand
00135018301•Haleon US Holdings LLC
$0.0525
per EA
TUMS E-X TABLET CHEWABLE
Brand
00135015405•Haleon US Holdings LLC
$0.0602
per EA
TUMS SMOOTHIES CHEW TABLET
Brand
00135024502•Haleon US Holdings LLC
$0.0602
per EA
TUMS E-X TABLET CHEWABLE
Brand
00135007625•Haleon US Holdings LLC
$0.0631
per EA

Data Source

Pricing data sourced from the National Average Drug Acquisition Cost (NADAC) survey, published by the Centers for Medicare & Medicaid Services (CMS). Updated weekly.

Disclaimer

This site is for informational purposes only and does not constitute medical, pharmaceutical, or financial advice. NADAC prices are survey-based estimates and may not reflect actual acquisition costs at any specific pharmacy.

Navigate

HomeAboutManufacturersDrug MarketsTherapeutic ClassesTrendsArticlesPricingContact

© 2026 NADAC Intelligence. All rights reserved. Not affiliated with CMS or any government agency.

Terms of ServicePrivacy Policy